The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[2-(4-Fluorophenyl)-4-(1-propyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrol-3-yl]pyridine ID: ALA1092617
PubChem CID: 9928889
Max Phase: Preclinical
Molecular Formula: C23H24FN3
Molecular Weight: 361.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCN1CC=C(c2c[nH]c(-c3ccc(F)cc3)c2-c2ccncc2)CC1
Standard InChI: InChI=1S/C23H24FN3/c1-2-13-27-14-9-17(10-15-27)21-16-26-23(19-3-5-20(24)6-4-19)22(21)18-7-11-25-12-8-18/h3-9,11-12,16,26H,2,10,13-15H2,1H3
Standard InChI Key: XGLAAPICLZABCU-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-2.7144 -8.1747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0328 -8.6381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3816 -8.1331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6605 -7.3573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4845 -7.3836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9054 -6.6766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4987 -5.9567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9187 -5.2466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7453 -5.2552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.1501 -5.9798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7278 -6.6870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4255 -8.5914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1437 -8.1815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8556 -8.5984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8506 -9.4251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1277 -9.8330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4187 -9.4138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2417 -6.6445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4150 -6.6497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0006 -5.9403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4060 -5.2211 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2328 -5.2159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6529 -5.9299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.5624 -9.8437 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.0123 -4.5091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8381 -4.5154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2565 -3.8034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 7 2 0
13 14 1 0
2 3 1 0
14 15 2 0
7 8 1 0
15 16 1 0
3 4 2 0
16 17 2 0
17 12 1 0
1 12 1 0
18 19 2 0
8 9 2 0
4 5 1 0
9 10 1 0
5 1 2 0
10 11 2 0
11 6 1 0
18 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
4 18 1 0
5 6 1 0
15 24 1 0
1 2 1 0
21 25 1 0
25 26 1 0
12 13 2 0
26 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 361.46Molecular Weight (Monoisotopic): 361.1954AlogP: 5.38#Rotatable Bonds: 5Polar Surface Area: 31.92Molecular Species: BASEHBA: 2HBD: 1#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 9.26CX LogP: 4.45CX LogD: 2.59Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: -0.68
References 1. Nakao A, Ohkawa N, Nagasaki T, Kagari T, Doi H, Shimozato T, Ushiyama S, Aoki K.. (2010) Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 2., 20 (8): [PMID:20346666 ] [10.1016/j.bmcl.2010.03.022 ] 2. Nakao A, Ohkawa N, Nagasaki T, Kagari T, Doi H, Shimozato T, Ushiyama S, Aoki K.. (2010) Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 3., 20 (16): [PMID:20637613 ] [10.1016/j.bmcl.2010.06.122 ]